Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Gogtay, P. Niphadkar, S. Rajan, I. Bubna, S. Srisvastava, M. Repal, P. Londhe, S. Jadhav (Mumbai, India). Evaluation of the usability, confidence and satisfaction of a novel dry powder inhaler for obstructive airway disease (OAD). Eur Respir J 2010; 36: Suppl. 54, 4542

Member's Comments

No comment yet.

Related content which might interest you: Patient preference for and satisfaction with inhaler devices Source: Eur Respir Rev 2005; 14: 109-116 Year: 2005 Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Inhaler choice in primary practice Source: Eur Respir Rev 2005; 14: 117-122 Year: 2005 Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India Source: Annual Congress 2006 - The challenges of managing asthma in primary care Year: 2006 Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Inhaler treatment options in COPD Source: Eur Respir Rev 2005; 14: 102-108 Year: 2005 Handling and patient preference of dry powder inhalers for asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 Inhaler therapy in obstructive airways disease (OAD): prescription, compliance and technique Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006 Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Improving inhalation parameters through dry powder inhalers (DPIs) after an acute asthma exacerbation Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThaler®) in COPD patients Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Carbon footprint of severe asthma exacerbation management relative to Breezhaler dry powder inhaler Source: Virtual Congress 2021 – Environment and respiratory health Year: 2021 A 6 week study of the efficacy and safety of UK-500,001 dry powder for inhalation (DPI) in adults with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Training patients on how to use metered dose inhaler (MDI) by using the 2Tone will improve asthma quality of life (AQOL) Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Preference and quality of life of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN) Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Improving inhaler use in COPD and the role of patient preference Source: Eur Respir Rev 2005; 14: 85-88 Year: 2005 Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013